Facts & Figures

2018 revenues for the Olympus medical business reached a historical high (Figures are fiscal year revenues.) 1998:184,098million yen, 2008:353,269million yen,  2018:616,331million yen.
More than 60% of Olympus R and D (Research and development) expenditures are dedicated to the medical business (for the fiscal year ending March 2018.)
11.4% of net sales went toward R and D (Research and development) expenditures in the 2018 fiscal year.
35,933 employees work for Olympus worldwide. Japan:13,032, Asia and Pacific:10,501, EMEA:7,108, Americas:5,292 (as of March 2018.)
Growth of the Olympus workforce.1919:83, 1979:5,600, 2000:18,999, 2018:35,933 (as of March 2018.)
22,408 Olympus employees work in its medical sector, which makes up Olympus’ largest business (as of March 2018.)
To support customers, Olympus has approximately 200 endoscopic repair and service sites worldwide (as of March 2018.)
Olympus is the leader in gastrointestinal endoscopic equipment with more than 70% global market share (as of March 2018.)
Yasuo Takeuchi is Olympus’ 17th President.
Check out one of the 191 social media accounts that Olympus has worldwide to connect with its customers, employees, and stakeholders (as of March 2018.)
Olympus has 99 group companies in 36 countries (as of March 2018.)
Olympus holds approximately 20,000 patents worldwide. 42% of Olympus’ patents were granted in the medical field (as of March 2018.)
275 awards. Since 1966, Olympus has been consistently honored with national and international design awards, including the prestigious Red Dot and iF Awards, for its innovative product designs (as of August 2018.)
Olympus produced 5 million units of the first generation micro([mju:] or Infinity Stylus) which was launched in 1991 and became one of Olympus’ best-selling cameras.